Motive Launches AI-Powered Motive Analytics to Transform How UK Teams Leverage Data, Turning Hours of Analysis Into Real-Time Insights in Seconds April 8, 2026 No more wasting hours combing through hard-to-read databases and reports—new AI-powered analytics solution designed to help teams gain instant insights so they can make better decisions faster Includes a conversational AI for physical operations designed to instantly surface answers from the full range of operational data Motive brings together across the organisation
UK Investors Back Narwhal Labs With £20 Million Investment to Launch DeepBlue Enterprise-Grade Agentic AI April 8, 2026 - Purpose-built for regulated enterprise and government use, DeepBlue OS turns missed customer leads into revenue, deployable in minutes with no setup cost
Construction firms slash jobs after biggest-ever cost inflation rise April 8, 2026 Construction businesses cut jobs at a faster pace in March while the month-to-month inflation rise was the largest on record in a survey that has existed for 29 years. S&P Global said the difference in a reading for cost inflation between February and March was the largest it had ever recorded since data collection began [...]
Londonmaxxing could save the capital’s jobs market April 8, 2026 Can Londonmaxxing help revive the capital's flailing job market? Employment expert Kevin Fitzgerald thinks so.
Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients April 8, 2026 This record closing is the largest raise ever achieved by a fully independent European fund dedicated to Biopharma, validating Jeito’s patient-driven investment strategy, its multidisciplinary, collaborative expertise spanning from science to commercialization of medicines, and value creation In five years, Jeito Capital has tripled its assets under management to €1.6 billion, firmly establishing itself among the top-tier global Biopharma investors Jeito II will build on Jeito I’s proven and differentiated strategy, investing in the most promising clinical Biopharma companies which address unmet patient needs and severe diseases, accelerate breakthrough therapeutic innovation, and deliver transformative benefits for patients This fundraise represents significant momentum for European Biopharma, strengthening its financial firepower and expertise to develop the next generation of global champions
N3XT and Zodia Markets Partner to Enable 24/7 Instant USD Payments Across Zodia’s Institutional Digital Asset Ecosystem April 8, 2026 N3XT, the blockchain-powered narrow bank built for instant, programmable B2B payments, and Zodia Markets, the digital asset platform enabling institutional capital through stablecoins, today announced a partnership to deliver real-time U.S. dollar settlement across Zodia Markets’ client base. The collaboration tackles a core friction in digital asset markets, where fragmented banking access and restricted operating [...]
MiQ Acquires Rocket Lab to Accelerate AI-Powered App Growth Globally April 7, 2026 Deal brings in-app growth and total-market reach together in one unified advertising solution
MFS software platform put up for sale after lender’s collapse April 7, 2026 A software platform developed for Market Finance Solutions has been put up for sale by administrators following the lender’s collapse, City AM can reveal. The software, which has been designed to be used in conjunction with Salesforce, was built as an “automated lending platform” including sales, underwriting and ‘KYC’ identity checks for new customers. “The [...]
Cloudflare and GoDaddy Partner to Help Enable an Open Agentic Web April 7, 2026 New integration and support for open standards including Agent Name Service (ANS) and Web Bot Auth will provide transparency and trust for the AI era
WRITER Survey Finds 60% of Companies Plan to Lay Off Employees Who Won’t Adopt AI April 7, 2026 C-suite executives report they’re creating a two-tiered workforce: 92% are actively cultivating a new class of “AI elite” employees; 75% say their company’s AI strategy is “more for show” than real guidance